[Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature].
Cystic adenoid carcinoma, which generally develops in the salivary glands, is a rare primary lung tumor. Locoregional treatment classically associates surgery and radiotherapy. Approximately half of the patients develop metastases; appropriate treatment with chemotherapy remains to be defined. We report the case of a woman who developed lung and pleural metastases of a right submaxillary cystic adenoid carcinoma. Chemotherapy with paclitaxel provided partial tumor response after three cycles. We present a review of the literature on chemotherapy for cystic adenoid carcinoma.
Perrot
E
E
Service de Pneumologie et de Maladies Infectieuses, CHU, Saint-Pierre, Ile de La Réunion. em.perrot@wanadoo.fr
Davy
N
N
Poubeau
P
P
Arvin-Berod
C
C
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D003528:Carcinoma, Adenoid Cystic / Q000188:drug therapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D017239:Paclitaxel / Q000627:therapeutic use*; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D012468:Salivary Gland Neoplasms / Q000473:pathology*; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel